What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to officially disseminate Boston Scientific's financial results for the fourth quarter and full year ended December 31, 2018, through an accompanying press release.

Where can I find the detailed financial results?

The detailed financial results are located in the press release furnished as Exhibit 99.1 to this 8-K filing.

Does this filing contain new operational guidance or outlooks?

This specific 8-K filing itself does not contain new operational guidance or outlooks. Investors should review the furnished press release (Exhibit 99.1) for any such forward-looking statements or commentary provided by the company.

What does it mean that the information is 'furnished' and not 'filed'?

When information is 'furnished' under Item 2.02, it means the SEC is made aware of the information, but it is not considered formally 'filed' for certain liability purposes under the Securities Exchange Act of 1934. This is a common practice for earnings releases. However, investors still rely on this information for investment decisions.

BSX 8-K: Earnings & Results

Summary

Boston Scientific Corporation (BSX) filed an 8-K on February 6, 2019, primarily to furnish its fourth quarter and full-year 2018 earnings press release. This filing provides investors with the company's official financial results for the period ended December 31, 2018. While the 8-K itself is brief, the accompanying press release contains the detailed financial performance data and management's commentary, which are crucial for understanding the company's operational and financial health.

Key Highlights

1Boston Scientific reported its financial results for the fourth quarter and full year ended December 31, 2018.
2The company filed an 8-K to provide investors with access to these results via a press release.
3The press release (Exhibit 99.1) contains the detailed financial performance for the specified periods.
4Information furnished under Item 2.02 is not deemed 'filed' for regulatory purposes, meaning it doesn't automatically incur liabilities under Section 18 of the Exchange Act.
5Investors should refer to the furnished press release for specific financial metrics, revenue figures, and earnings per share.
6The filing serves as a formal announcement of BSX's performance in late 2018.

BOSTON SCIENTIFIC CORP 8-K Report, Financial Results (Feb 6, 2019)

Summary

Key Highlights

Frequently Asked Questions